Mostafa, M., Ghaly, M., Sayed, H., Abd ElAziz, M. (2024). Effects of COVID-19 Fear and Anxiety on Symptoms Severity, Sleep Quality, and Mood in Patients with Fibromyalgia in Ismailia. Suez Canal University Medical Journal, 27(3), 1-12. doi: 10.21608/scumj.2024.369042
Mira Mostafa; Mona S. Ghaly; Haydy H. Sayed; Maha A. Abd ElAziz. "Effects of COVID-19 Fear and Anxiety on Symptoms Severity, Sleep Quality, and Mood in Patients with Fibromyalgia in Ismailia". Suez Canal University Medical Journal, 27, 3, 2024, 1-12. doi: 10.21608/scumj.2024.369042
Mostafa, M., Ghaly, M., Sayed, H., Abd ElAziz, M. (2024). 'Effects of COVID-19 Fear and Anxiety on Symptoms Severity, Sleep Quality, and Mood in Patients with Fibromyalgia in Ismailia', Suez Canal University Medical Journal, 27(3), pp. 1-12. doi: 10.21608/scumj.2024.369042
Mostafa, M., Ghaly, M., Sayed, H., Abd ElAziz, M. Effects of COVID-19 Fear and Anxiety on Symptoms Severity, Sleep Quality, and Mood in Patients with Fibromyalgia in Ismailia. Suez Canal University Medical Journal, 2024; 27(3): 1-12. doi: 10.21608/scumj.2024.369042
Effects of COVID-19 Fear and Anxiety on Symptoms Severity, Sleep Quality, and Mood in Patients with Fibromyalgia in Ismailia
1Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Egypt.
2Department of Psychiatry, Faculty of Medicine, Suez Canal University, Egypt.
Abstract
Background: Those who have fibromyalgia may be more sensitive to pain than those who don't. Some SARS-CoV-2 virus carriers will develop serious illnesses and need medical care. Therefore, people with fibromyalgia are more likely to experience worry and anxiety when COVID-19 illness first manifests. Aim: To determine the effects of COVID-19 fear and anxiety on symptoms severity, sleep quality, and mood in patients with fibromyalgia in Suez Canal university and to determine the prevalence of the effects of COVID-19 fear and anxiety on symptoms severity, sleep quality, and mood in patients with fibromyalgia in Suez Canal university. Patients and Methods: Following clearance from the Research Ethics Committee, this cross-sectional investigation was conducted in rheumatology outpatient clinics at Suez Canal University Hospital. There were 43 fibromyalgia patients in the research. To evaluate symptom intensity, sleep quality, and mood, patients were given the revised fibromyalgia impact questionnaire (FIQR), pittsburg sleep quality index (PSQI), and hospital anxiety depression scale (HADS). Additionally, the Coronavirus Anxiety Scale (CAS) and the dread of COVID-19 Scale (FCV-19S) are used to measure the severity of COVID-19 anxiety and dread. Results: We found that most of our patients had no fear or anxiety towards COVID-19 to begin with. This could be attributed to the fact that about 50% of patients were living in rural areas, around 65% had low socioeconomic status, also about 65% were illiterate or had only a high school degree. Conclusion: In contrast to COVID-19 anxiety, which does not affect symptom intensity, sleep quality, or mood in fibromyalgia patients, COVID-19 fear has a small but substantial impact on these variables.